Services
New directions in healthcare development
Empowering health through smart solutions
In the field of healthcare development, InnovITech has developed valuable competencies through several research and development projects.
Our company’s first healthcare R&D project was the CTA - CML (Chronic Myeloid Leukemia) Treatment Assistant, which was later expanded to include two additional disease types (Follicular Lymphoma, CLL - Chronic Lymphocytic Leukemia). The medical professional supervision of the development was provided by the Institute of Pathology and Experimental Cancer Research at Semmelweis University. The goal of the project was to provide personalized, condition-specific information to patients undergoing treatment for the mentioned diseases, enabling users to receive information about treatment options and schedules based on their current condition. Thus, the system offers the opportunity to monitor and schedule therapies for patients, treating physicians, and laboratory staff.
The Microbiolance project was implemented with the professional participation of UD-GenoMed Ltd. (a spin-off company of the Institute of Biochemistry and Molecular Biology at the University of Debrecen) and the Department of Psychiatry and Psychotherapy at Semmelweis University. The aim of the project was to create an IT system that enables the automated analysis of the relationship between gut flora composition and various psychiatric disorders.
The GenomeAtlas research and development project’s biotechnology partner was UD-GenoMed Ltd. (a spin-off company of the Institute of Biochemistry and Molecular Biology at the University of Debrecen). The goal of the project was to explore and simulate the spatial structure of the genome, representing a completely new direction in genomics development.
Our ongoing, genomics-based development aims to create an IT decision support system for the oncology field, based on bioinformatics and imaging diagnostic artificial intelligence, which assists in early diagnostics and the development of personalized therapies. InnovITech is participating as consortium leader in the development, in partnership with GE Healthcare Hungary Ltd. and the Faculty of Mechanical Engineering, Informatics, and Electrical Engineering at Széchenyi István University. The Petz Aladár County Teaching Hospital of Győr-Sopron County and the Oncology Clinic of the University of Debrecen are participating as clinical partners in the project.
In addition to our R&D projects, our company has participated in the development of a clinical and therapeutic data management system that required EESZT (National eHealth Infrastructure) integration, resulting in the acquisition of valuable specific knowledge.
These developments have resulted in the following general competencies, which represent capabilities applicable to the general healthcare sector:
Clinical data management for dynamically expandable disease types (e.g., tumor, autoimmune, and neurodegenerative diseases), enabling data management related to disease diagnostics.
Monitoring of therapies and pharmaceutical treatments: It is possible to record pharmaceutical therapies and support their execution and supervision, also via mobile applications.
Management of test results: Monitoring of blood tests, imaging results, and genomic analysis findings.
Reporting and sending reports to clinicians.
Evaluation of therapy effectiveness: Based on test results, the effectiveness of therapies can be automatically analyzed according to a rule system defined for specific test values.
Development of bioinformatics pipelines.
Analysis of correlations between microbiome patterns and clinical data: Correlation studies and analyses between microbiome metagenomic patterns and clinical data, which can be performed not only for example disease models but also for examining the development of diseases resulting from changes in microbiome composition.